Beta-blockers and the treatment of hypertension : it is time to move on
Wiysonge, Charles Shey
Opie, Lionel H.
MetadataShow full item record
Existing solid scientific evidence with hard outcome data should be the basis for treatment guidelines, and where such evidence is lacking, we must invest in research. A case in point is the initiation of antihypertensive treatment with a beta-blocker. Beta-blockers are pharmacological agents that block the action of endogenous catecholamines on beta-adrenergic receptors, part of the sympathetic nervous system which mediates the ‘fight or flight’ response.
Please cite this item using this persistent URLhttp://hdl.handle.net/10019.1/19362
The following license files are associated with this item: